PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 61 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,130,000 | +16.4% | 73,378 | -1.7% | 0.00% | 0.0% |
| Q3 2016 | $971,000 | +29.0% | 74,653 | +37.9% | 0.00% | 0.0% |
| Q2 2016 | $753,000 | +15.5% | 54,133 | +25.9% | 0.00% | 0.0% |
| Q1 2016 | $652,000 | -17.8% | 42,998 | +2.9% | 0.00% | 0.0% |
| Q4 2015 | $793,000 | +0.4% | 41,787 | +0.5% | 0.00% | 0.0% |
| Q3 2015 | $790,000 | -27.7% | 41,564 | -1.9% | 0.00% | 0.0% |
| Q2 2015 | $1,092,000 | +15500.0% | 42,385 | +19522.7% | 0.00% | – |
| Q1 2015 | $7,000 | -12.5% | 216 | 0.0% | 0.00% | – |
| Q4 2014 | $8,000 | – | 216 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,600,410 | $33,805,000 | 33.22% |
| Abingworth LLP | 1,041,131 | $13,535,000 | 8.41% |
| Roumell Asset Management, LLC | 197,347 | $2,566,000 | 5.65% |
| Trellus Management Company, LLC | 89,700 | $1,166,000 | 2.12% |
| Prosight Management, LP | 148,682 | $1,933,000 | 1.21% |
| Broadfin Capital, LLC | 477,607 | $6,209,000 | 0.97% |
| HIGHLAND CAPITAL MANAGEMENT LP | 959,278 | $12,471,000 | 0.64% |
| ARMISTICE CAPITAL, LLC | 580,000 | $7,540,000 | 0.58% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,500 | $1,346,000 | 0.52% |
| Opus Point Partners Management, LLC | 20,000 | $260,000 | 0.51% |